Document:

Registration Rights Agreement

 Exhibit 4.5 
  
  
  
 SOLTA MEDICAL, INC.

 REGISTRATION RIGHTS AGREEMENT 
 Dated as of February 22, 2010 
  
  
  

 TABLE OF CONTENTS 
  

					
	  	  	 	  	 Page

	ARTICLE I
	
	DEFINITIONS
			
	Section 1.1.	  	Definitions	  	1
	Section 1.2.	  	General Interpretive Principles	  	2
	
	ARTICLE II
	
	REGISTRATION RIGHTS
			
	Section 2.1.	  	Certain Definitions	  	3
	Section 2.2.	  	Shelf Registration	  	3
	Section 2.3.	  	Expenses of Registration	  	6
	Section 2.4.	  	Obligations of the Company	  	7
	Section 2.5.	  	Indemnification.	  	8
	Section 2.6.	  	Information by Holder	  	10
	Section 2.7.	  	Transfer of Registration Rights	  	10
	Section 2.8.	  	Delay of Registration	  	10
	Section 2.9.	  	Rule 144 Reporting	  	10
	Section 2.10.	  	Termination of Registration Rights	  	11
	
	ARTICLE III
	
	ADDITIONAL AGREEMENTS OF THE PARTIES
			
	Section 3.1.	  	Further Assurances	  	11
	
	ARTICLE IV
	
	MISCELLANEOUS
			
	Section 4.1.	  	Entire Agreement	  	11
	Section 4.2.	  	Specific Performance	  	11
	Section 4.3.	  	Governing Law	  	11
	Section 4.4.	  	Amendment and Waiver	  	11
	Section 4.5.	  	Binding Effect	  	12
	Section 4.6.	  	Termination	  	12
	Section 4.7.	  	Notices	  	12
	Section 4.8.	  	Severability	  	12
	Section 4.9.	  	Counterparts	  	12
	Section 4.10.	  	Venue, Waiver of Jury Trial	  	12

  

 -i- 

 REGISTRATION RIGHTS AGREEMENT 
 This REGISTRATION RIGHTS AGREEMENT is made as of February 22, 2010, by and between Solta Medical, Inc., a Delaware corporation
(“Company”), and each of the persons set forth on Schedule A hereto (each an “Investor” and, collectively, the “Investors”). 
 WHEREAS, the Company and the Investors have entered into a Payoff and Release Agreement (the “Release Agreement”) of even
date herewith, pursuant to which the Company will issue shares of its common stock to the Investors in accordance with the terms set forth therein; and 
 WHEREAS, the Investors and the Company desire to set forth certain registration and related rights as set forth herein. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties mutually agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 Section 1.1. Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 
 “Adverse Disclosure” means public disclosure of material non-public information which, in the reasonable judgment of the
Company: (i) would be required to be made in any report or registration statement filed with the SEC by the Company so that such report or registration statement would not be materially misleading; (ii) would not be required to be made at
such time but for the filing, effectiveness or continued use of such report or registration statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly. 
 “Affiliate” means, with respect to any Person, any other Person that controls, is controlled by, or is under common control
with such Person. The term “control”, as used with respect to any Person, means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of
voting securities, by contract or otherwise. “Controlled” and “controlling” have meanings correlative to the foregoing. 
 “Agreement” means this Registration Rights Agreement, as the same may be amended, supplemented, restated or modified. 
 “Beneficial Ownership” and “Beneficially Own” and similar terms have the meaning set forth in Rule 13d-3
under the Exchange Act. 
 “Business Day” means any day, other than a Saturday, Sunday or one on which banks
are authorized or required by law to be closed in San Francisco, California. 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder, as the same may be amended from time to time. 
 “Merger
Agreement” means that certain Agreement and Plan of Merger dated on or around the date hereof, by and among the Company, Apollo ATC Merger Corp., Aesthera Corporation and Dana Mead as Holder Representative. 
 “Person” means an individual, partnership, corporation, business trust, joint stock company, trust, unincorporated
association, joint venture, limited liability company or any other entity of whatever nature, and shall include any successor (by merger or otherwise) of such entity. 
 “Rule 144” means Rule 144 under the Securities Act. 
 “SEC” means the United States Securities and Exchange Commission. 
 “Securities Act”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as the same may be amended from time to time. 
 Section 1.2. General Interpretive Principles. 
 (a) The name assigned
to this Agreement and the section captions used herein are for convenience of reference only and shall not be construed to affect the meaning, construction or effect hereof. 
 (b) Unless otherwise specified, the terms “hereof,” “herein” and similar terms refer to this Agreement as a whole, and
references herein to Articles or Sections refer to Articles or Sections of this Agreement. 
 (c) For purposes of this
Agreement, the words, “include,” “includes” and “including,” when used herein, shall be deemed in each case to be followed by the words “without limitation.” 
 (d) The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or
interpretation arises, this Agreement will be construed as if drafted jointly by the parties and no presumption or burden of proof will arise favoring or disfavoring any party because of the authorship of any provision of this Agreement. 

 

 -2- 

 ARTICLE II 
 REGISTRATION RIGHTS 
 The Company hereby grants to
each of the Holders (as defined below) the registration rights set forth in this Article II, with respect to the Registrable Securities (as defined below) owned by such Holders. 
 Section 2.1. Certain Definitions. As used in this Article II: 
 (a) “Holder” (collectively, “Holders”) means (i) the Investors and (ii) any Affiliate of each of
the Investors or the limited or general partners of each of the Investors that the Investors designate in writing as a Holder, in each case to the extent holding Registrable Securities, securities exercisable or convertible into Registrable
Securities or securities exercisable for securities convertible into Registrable Securities. 
 (b) “Registration
Statement” means a registration statement or registration statements of the Company filed under the 1933 Act covering the Registrable Securities. References to the Registration Statement shall include any Prospectus. 
 (c) “Prospectus” means the prospectus included in any Shelf Registration Statement, all amendments and supplements to such
prospectus, including post-effective amendments, and all other material incorporated by reference in such prospectus. 
 (d)
“register”, “registered” and “registration” refer to a registration effected by filing with the SEC a Registration Statement in compliance with the Securities Act, and the declaration or ordering by
the SEC of the effectiveness of such Registration Statement. 
 (e) “Registrable Securities” means the shares
of common stock of the Company issued to the Investors pursuant to the Release Agreement until the earliest to occur of (a) the date on which both a Registration Statement covering such securities has been declared effective by the SEC and such
security has been disposed of pursuant to such effective Registration Statement, (b) the date on which such security is sold pursuant to Rule 144, (c) the date on which such security ceases to be outstanding or (d) the date on which
the Holder thereof, together with its Affiliates, is able to dispose of all of its Registrable Securities in any 90 day period pursuant to Rule 144 (or any similar or analogous rule promulgated under the Securities Act). 
 (f) “Shelf Registration Statement” means the Registration Statement. References to Shelf Registration Statement shall
include any Prospectus. 
 Section 2.2. Shelf Registration 
 (a)(i) Mandatory Registration. The Company shall, as soon as practicable but in any event within fifteen (15) days of the Closing
Date (as defined in the Merger Agreement), prepare and file with the SEC the Registration Statement on Form S-3 covering the resale of all of the Registrable Securities. The Company shall use its commercially reasonable efforts to have the
Registration Statement declared effective by the SEC as soon as practicable. The Company shall use its commercially reasonable efforts to file with the SEC in accordance with Rule 424 under the 1933 Act the final prospectus to be used in connection
with sales pursuant to such Registration Statement no later than the deadline required by Rule 424. 
  

 -3- 

 (ii) Allocation of Registrable Securities. The initial number of Registrable
Securities included in the Registration Statement and any increase or decrease in the number of Registrable Securities included therein shall be allocated pro rata among the Holders based on the number of Registrable Securities held by each Holder
at the time the Registration Statement covering such initial number of Registrable Securities or increase or decrease thereof is declared effective by the SEC. In the event that a Holder sells or otherwise transfers any of such Holder’s
Registrable Securities, each transferee that becomes a Holder shall be allocated a pro rata portion of the then remaining number of Registrable Securities included in such Registration Statement for such transferor. Any shares of Common Stock
included in a Registration Statement and which remain allocated to any Person which ceases to hold any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Holders, pro rata based on the number of
Registrable Securities then held by such Holders which are covered by such Registration Statement. 
 (b) Suspension of
Filing or Registration. If the Company shall furnish to the Holders a certificate signed by the Chief Executive Officer or Chief Financial Officer of the Company, stating that the filing, effectiveness or continued use of a Shelf Registration
Statement would require the Company to make an Adverse Disclosure, then the Company shall have a period of not more than 60 days (or such longer period as the majority-in-interest of the Investors shall consent to in writing) within which to delay
the filing or effectiveness of such Shelf Registration Statement or, in the case of a Shelf Registration Statement that has been declared effective, to suspend the use by Holders of such Shelf Registration Statement (in each case, a “Shelf
Suspension”); provided, however, that, unless consented to in writing by a majority-in-interest of the Investors, the Company shall not be permitted to exercise a Shelf Suspension more than twice during any 12-month period for
each Shelf Registration Statement. In the case of a Shelf Suspension that occurs after the effectiveness of a Shelf Registration Statement, the Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase of, or
offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders upon the termination of any Shelf Suspension, and (i) in the case of a Shelf Registration
Statement that has not been declared effective, shall promptly thereafter file a Shelf Registration Statement and use its commercially reasonable efforts to have such Shelf Registration Statement declared effective under the Securities Act and
(ii) in the case of an effective Shelf Registration Statement, shall amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the Prospectus
as so amended or supplemented as the Holders may reasonably request. The Company agrees, if necessary, to supplement or make amendments to the applicable Shelf Registration Statement, if required by the registration form used by the Company for the
shelf registration or by the instructions applicable to such registration form or by the Securities Act or the rules or regulations promulgated thereunder. 
 (c) The Company shall use its commercially reasonable efforts to take all actions reasonably necessary to ensure that the transactions contemplated herein are effected as so contemplated in
Section 2.2(a) hereof, and to submit to the SEC, within five (5) Business

  

 -4- 

 
Days after the Company learns that no review of a Shelf Registration Statement will be made by the staff of the SEC or that the staff has no further comments on a Shelf Registration Statement, as
the case may be, a request for acceleration of effectiveness (or post effective amendment, if applicable) of such Shelf Registration Statement to a time and date not later than 48 hours after the submission of such request. 
 (d) Any reference herein to a registration statement or prospectus as of any time shall be deemed to include any document incorporated, or
deemed to be incorporated, therein by reference as of such time and any reference herein to any post-effective amendment to a registration statement as of any time shall be deemed to include any document incorporated, or deemed to be incorporated,
therein by reference as of such time. Any reference to a prospectus as of any time shall include any supplement thereto, preliminary prospectus, or any free writing prospectus in respect thereof. 
 (e) In connection with the filing of the Shelf Registration Statement, the Company shall: 
 (i) prepare and file with the SEC within the time periods specified in Section 2.2(a), a Shelf Registration Statement on any form
which may be utilized by the Company and which shall register all of the Registrable Securities for resale by the holders thereof in accordance with such method or methods of disposition as may be specified by the Investors and use commercially
reasonable efforts to cause such Shelf Registration Statement to become effective as soon as reasonably practicable but in any case within the time periods specified in Section 2.2(a); 
 (ii) as soon as reasonably practicable prepare and file with the SEC such amendments and supplements to such Shelf Registration Statement
(including without limitation, any required post effective amendments) and the prospectus included therein as may be necessary to effect and maintain the effectiveness of such Shelf Registration Statement and as may be required by the applicable
rules and regulations of the SEC and the instructions applicable to the form of such Shelf Registration Statement; 
 (iii)
comply with the provisions of the Securities Act with respect to the disposition of all of the Registrable Securities covered by such Shelf Registration Statement in accordance with the intended methods of disposition by the Investors provided for
in such Shelf Registration Statement; 
 (iv) keep the Shelf Registration Statements current and continuously effective
pursuant to Rule 415 at all times until such date the Registrable Securities registered pursuant to each such applicable Shelf Registration Statement are no longer Registrable Securities. The Shelf Registration Statements shall not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading; and 
 (v) promptly notify the Investors (A) when such Shelf Registration Statement or the Prospectus included therein or any prospectus amendment or supplement or post-effective amendment has been filed,
and, with respect to such Shelf Registration Statement

  

 -5- 

 
or any post-effective amendment, when the same has become effective, (B) of any comments by the SEC with respect thereto or any request by the SEC for amendments or supplements to such Shelf
Registration Statement or prospectus or for additional information (the Company shall respond to such comments and requests from the SEC as promptly as reasonably possible), (C) of the issuance by the SEC of any stop order suspending the
effectiveness of such Shelf Registration Statement or the initiation or threatening of any proceedings for that purpose, (D) of the receipt by the Company of any notification with respect to the suspension of the qualification of the
Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose (in the cases of (C) and (D), the Company shall obtain the withdrawal of such stop order or suspension at the earliest
practicable time) or (E) if at any time when a prospectus is required to be delivered under the Securities Act, that such Shelf Registration Statement, prospectus, prospectus amendment or supplement or post-effective amendment does not conform
in all material respects to the applicable requirements of the Securities Act and the rules and regulations of the SEC thereunder or contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the circumstances then existing (the Company shall use its commercially reasonable efforts to promptly prepare a supplement or amendment to the Shelf Registration Statement to
conform to such requirements or to correct such untrue statement or omission, and deliver such number of copies of such supplement or amendment to the selling Holders as the selling Holders may reasonably request). 
 (f) In connection with a shelf registration, the Company may require each Holder whose Registrable Securities are covered by the shelf
registration, to furnish to the Company such information regarding the Holder, including, without limitation, its intended method of distribution of Registrable Securities as may be required in order to comply with the Securities Act. The Holder
agrees to notify the Company as promptly as practicable of any inaccuracy or change in information previously furnished by the Holder to the Company or of the occurrence of any event in either case that could cause the prospectus to contain an
untrue statement of a material fact regarding the Holder or its intended method of disposition of such Registrable Securities or omits to state any material fact regarding the Holder or its intended method of disposition of such Registrable
Securities required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly to furnish to the Company any additional information required to correct and update any
previously furnished information or required so that such prospectus shall not contain, with respect to the Holder or the disposition of such Registrable Securities, an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. If the Holder fails to provide to the Company any information required to be provided pursuant to this Section 2.2 after
the Holder became aware of the inaccuracy, omission or required change, the Company may suspend the use of the Shelf Registration Statement and the prospectus contained therein until such time as the Holder provides the required information to the
Company. 
 Section 2.3. Expenses of Registration. All expenses incurred in connection with all registrations
effected pursuant to Section 2.2, including all registration, SEC, stock exchange, filing and qualification fees (including state securities law fees and expenses), printing expenses, messenger and delivery expenses, escrow fees, accounting
fees, fees and disbursements of counsel for and independent public accountants of the Company, and fees and expenses of all Persons retained by the Company; provided, however, that the Company shall not be required to pay stock
transfer taxes or any discounts or selling commissions relating to Registrable Securities. 
  

 -6- 

 Section 2.4. Obligations of the Company. Whenever required under this Article II
to effect the registration of any Registrable Securities, the Company shall (in addition to the requirements set forth in Section 2.2(e) with respect to a Shelf Registration Statement), as expeditiously as reasonably possible: 
 (a) prepare and file with the SEC such amendments and supplements to such Registration Statement and the prospectus used in connection with
such Registration Statement as may be necessary to keep such Registration Statement effective and to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement in
accordance with the intended methods of disposition by sellers thereof set forth in such registration statement; 
 (b) furnish
to the Holders such numbers of copies of a prospectus, including all exhibits thereto and documents incorporated by reference therein and a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents
as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 
 (c) notify
each Holder of Registrable Securities covered by such Registration Statement as soon as reasonably practicable after notice thereof is received by the Company of any written comments by the SEC or any request by the SEC or any other federal or state
governmental authority for amendments or supplements to such Registration Statement or such prospectus or for additional information; 
 (d) notify each Holder of Registrable Securities covered by such Registration Statement, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening of any event as a result of which
the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in
the light of the circumstances then existing; 
 (e) notify each Holder of Registrable Securities covered by such Registration
Statement as soon as reasonably practicable after notice thereof is received by the Company of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or any order by the SEC or any other regulatory
authority preventing or suspending the use of any preliminary or final prospectus or the initiation or threatening of any proceedings for such purposes, or any notification with respect to the suspension of the qualification of the Registrable
Securities for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; 
 (f)
use its reasonable efforts to prevent the issuance of any stop order suspending the effectiveness of any Registration Statement or of any order preventing or suspending the use of any preliminary or final prospectus and, if any such order is issued,
to obtain the withdrawal of any such order as soon as practicable; 
  

 -7- 

 (g) use its commercially reasonable efforts to list the Registrable Securities covered by
such Registration Statement with NASDAQ or any securities exchange on which the Common Stock is then listed; 
 (h) provide and
cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable Registration Statement from and after a date not later than the effective date of such Registration Statement; 
 (i) use its reasonable efforts to comply with all applicable securities laws; and 
 (j) enter into and perform customary agreements and take such other commercially reasonable actions as are prudent and reasonably required
in order to expedite or facilitate the disposition of the Registrable Securities. 
 Section 2.5. Indemnification.

 (a) The Company will, and does hereby undertake to, indemnify and hold harmless each Holder of Registrable Securities, each of
such Holder’s officers, directors, employees, partners and agents, and each Person controlling such Holder, and the officers, directors, employees, partners and agents of each Person controlling such Holder, against all claims, losses, damages
and liabilities (or actions in respect thereto) to which they may become subject under the Securities Act, the Exchange Act, or other federal or state law arising out of or based on (A) any untrue statement (or alleged untrue statement) of a
material fact contained in any prospectus, offering circular or other similar document (including any related Registration Statement, notification, or the like) incident to any such registration, qualification or compliance, or based on any omission
(or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances in which they were made, (B) any violation or alleged violation by the
Company of any federal, state or common law rule or regulation applicable to the Company in connection with any such registration, qualification or compliance, or (C) any failure to register or qualify Registrable Securities in any state where
the Company or its agents have affirmatively undertaken or agreed that the Company will undertake such registration or qualification on behalf of the Holders of such Registrable Securities including pursuant to Section 2.5(j) (provided
that in such instance the Company shall not be so liable if it has undertaken its reasonable efforts to so register or qualify such Registrable Securities) and will reimburse, as incurred, each such Holder and each such director, officer, partner,
agent and controlling person, for any legal and any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability or action; provided that the Company will not be liable in any such
case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on any untrue statement or omission made in reliance and in conformity with written information furnished to the Company by such Holder expressly
for use therein. 
  

 -8- 

 (b) Each Holder will, and if Registrable Securities held by or issuable to such Holder are
included in such registration, qualification or compliance pursuant to this Article II, does hereby undertake to indemnify and hold harmless the Company, each of its directors, employees, agents and officers, and each Person controlling the Company
and its directors, employees, agents and officers, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any
such Registration Statement, prospectus, offering circular or other document, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading in light of
the circumstances in which they were made, and will reimburse, as incurred, the Company, each such other Holder, and each such director, officer, employee, agent, partner and controlling Person of the foregoing, for any legal or any other expenses
reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged
omission) was made in such Registration Statement, prospectus, offering circular or other document, in reliance upon and in conformity with written information furnished to the Company by such Holder expressly for use therein; provided,
however, that the liability of each Holder hereunder shall be limited to the net proceeds received by such Holder from the sale of securities under such Registration Statement. 
 (c) Each party entitled to indemnification under this Section 2.6 (the “Indemnified Party”) shall give notice to the
party required to provide such indemnification (the “Indemnifying Party”) of any claim as to which indemnification may be sought promptly after such Indemnified Party has actual knowledge thereof, and shall permit the Indemnifying
Party to assume the defense of any such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall be subject to approval by the Indemnified
Party (whose approval shall not be unreasonably withheld) and the Indemnified Party may participate in such defense at the Indemnifying Party’s expense if (i) representation of such Indemnified Party would be inappropriate due to actual or
potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding or (ii) the Indemnifying Party shall have failed to promptly assume the defense of such proceeding; and
provided further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Article II, except to the extent that such failure to give notice
shall materially adversely affect the Indemnifying Party in the defense of any such claim or any such litigation. No Indemnifying Party, in the defense of any such claim or litigation, may, without the consent of each Indemnified Party, consent to
entry of any judgment or enter into any settlement unless such settlement includes an unconditional release of such Indemnified Party from all liabilities on claims that are the subject matter of such claim or litigation. 
 (d) In order to provide for just and equitable contribution in case indemnification is unavailable to an Indemnified Party (by reason of
legal prohibition or otherwise), the Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, claims, damages or liabilities in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions which resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged

  

 -9- 

 
untrue statement of material fact or omission or alleged omission to state a material fact, has been made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party,
and such party’s relative intent, knowledge, access to information and opportunity to correct or prevent such actions; provided, however, that, in any case, (i) no Holder will be required to contribute any amount in excess of
the public offering price of all securities offered by it pursuant to such Registration Statement (less all applicable fees and discounts), and (ii) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
 (e) The indemnity and contribution agreements contained herein are in addition to any liability that the Indemnifying Party may have to the Indemnified Parties and shall remain in full force and effect regardless of any investigation made
by or on behalf of the Indemnified Party or any officer, director or controlling Person of such Indemnified Party and shall survive the transfer of the Registrable Securities. 
 Section 2.6. Information by Holder. The Holder or Holders of Registrable Securities included in any registration shall furnish
to the Company such information regarding such Holder or Holders and the distribution proposed by such Holder or Holders as the Company may reasonably request in writing and as shall be required in connection with any registration, qualification or
compliance referred to in this Article II. 
 Section 2.7. Transfer of Registration Rights. The rights contained in
Section 2.2 hereof to cause the Company to register the Registrable Securities, and the other rights set forth in this Article II, may not be assigned or otherwise conveyed by the Investors. 
 Section 2.8. Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise
delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Article II. 
 Section 2.9. Rule 144 Reporting. With a view to making available to the Holders the benefits of certain rules and regulations of the SEC that may permit the sale of the Registrable Securities
to the public without registration, the Company agrees to use its commercially reasonable efforts to: 
 (a) make and keep
current public information available, within the meaning of Rule 144 or any similar or analogous rule promulgated under the Securities Act; and 
 (b) file with the SEC, in a timely manner, all reports and other documents required of the Company under the Securities Act and Exchange Act; 
 (c) as long as any Holder owns any Registrable Securities, furnish in writing upon such Holder’s written request a written statement by
the Company that it has complied with the reporting requirements of Rule 144 and of the Securities Act and Exchange Act; and 
 (d) undertake any additional actions reasonably necessary to maintain the availability of the use of Rule 144. 
  

 -10- 

 Section 2.10. Termination of Registration Rights. The right of any Holder to
request registration or inclusion in any registration pursuant to this Agreement shall terminate on the earlier of (i) such date on which all shares of Registrable Securities held or entitled to be held upon conversion by such Holder may
immediately be sold under Rule 144 during any ninety (90) day period, and (ii) such date on which such Holder no longer holds any Registrable Securities. 
 ARTICLE III 
 ADDITIONAL AGREEMENTS OF THE PARTIES 
 Section 3.1. Further Assurances. From time to time, at the reasonable request of any other party hereto and without further
consideration, each party hereto shall execute and deliver such additional documents and take all such further action as may be necessary or appropriate to consummate and make effective, in the most expeditious manner practicable, the transactions
contemplated by this Agreement. 
 ARTICLE IV 
 MISCELLANEOUS 
 Section 4.1. Entire
Agreement. This Agreement, that certain Payoff and Release Agreement dated on or around the date hereof and that certain Lock-Up Agreement dated on or around the date hereof constitute the entire understanding and agreement between the parties
as to the matters covered herein and supersede and replace any prior understanding, agreement or statement of intent, in each case, written or oral, of any and every nature with respect thereto. 
 Section 4.2. Specific Performance. The parties hereto agree that the obligations imposed on them in this Agreement are special,
unique and of an extraordinary character, and that, in the event of breach or threatened breach by any party, damages would not be an adequate remedy and each of the other parties shall be entitled to specific performance and injunctive and other
equitable relief in addition to any other remedy to which it may be entitled, at law or in equity; and the parties hereto further agree to waive any requirement for the securing or posting of any bond in connection with the obtaining of any such
injunctive or other equitable relief. 
 Section 4.3. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware applicable to contracts entered into and performed entirely within such State. 
 Section 4.4. Amendment and Waiver. 
 (a) This Agreement may be amended
or modified, and any provision hereof may be waived, in whole or in part, at any time pursuant to an agreement in writing executed by the Company and a majority-in-interest of the Investors. 
 (b) Any failure by any party at any time to enforce any of the provisions of this Agreement shall not be construed a waiver of such
provision or any other provisions hereof. 
  

 -11- 

 Section 4.5. Binding Effect. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the parties’ successors and permitted assigns. 
 Section 4.6. Termination. This Agreement shall terminate only by written consent of the Company and a majority-in-interest of the Investors or upon the earlier to occur of: (i) the dissolution or liquidation of the Company
and (ii) such date on which there no longer remain any Registrable Securities. 
 Section 4.7. Notices. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via facsimile or email at the facsimile number or email address specified in this Section prior to 6:30 p.m. (Pacific Time) on a Business Day, (b) the next Business Day after the date of transmission, if such notice or
communication is delivered via facsimile or email at the facsimile number or email address specified in this Section on a day that is not a Business Day or later than 6:30 p.m. (Pacific Time) on any Business Day, (c) the Business Day
following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses, facsimile numbers and email addresses for such notices and
communications are those set forth on the signature pages hereof, or such other address or facsimile number as may be designated in writing hereafter, in the same manner, by any such Person. 
 Section 4.8. Severability. If any portion of this Agreement shall be declared void or unenforceable by any court or
administrative body of competent jurisdiction, such portion shall be deemed severable from the remainder of this Agreement, which shall continue in all respects valid and enforceable. 
 Section 4.9. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an
original, but all of which together shall constitute a single instrument. 
 Section 4.10. Venue, Waiver of Jury
Trial. THE COMPANY AND THE INVESTORS HEREBY IRREVOCABLY SUBMIT TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN SANTA CLARA COUNTY, CALIFORNIA FOR THE ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR THE
INVESTORS HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN, AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR THE INVESTORS, ANY CLAIM
THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, EACH KNOWINGLY, VOLUNTARILY AND
INTENTIONALLY WAIVE IRREVOCABLY, ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS ARISING OUT OF OR

  

 -12- 

 
RELATING TO THIS AGREEMENT AND SUCH PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. 
 [The remainder of this page intentionally left blank] 
  

 -13- 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	SOLTA MEDICAL, INC.
		
	By:	 	 /s/ Stephen J. Fanning

	Name:	 	Stephen J. Fanning
	Title:	 	President and Chief Executive Officer
	
	Address for Notice:
	
	 25881 Industrial Boulevard

	 Hayward, CA 94545

  

			
	Facsimile No.:	 	 510-782-2287

	Telephone No.:	 	 877-782-2286

	Attn:	 	 Chief Executive Officer

	
	with a copy (which shall not constitute notice) to:
	
	Wilson Sonsini Goodrich & Rosati
	Professional Corporation
	One Market, Spear Tower, Suite 3300
	San Francisco, CA 94105
	Attention:        Robert Ishii
	Facsimile No.: (415) 947-2099
	Telephone No.: (415) 947-2000

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	INVESTORS
	
	PINNACLE VENTURES, L.L.C.
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Operating Officer

  

			
	Address for Notice:
	
	 130 Lytton Avenue, Suite 220

	 Palo Alto, CA 94301
  

	Facsimile No.:	 	 (650) 926-7801

	Telephone No.:	 	 (650) 926-7805

	Attn:	 	 Robert N. Savoie

	
	with a copy (which shall not constitute notice) to:

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	INVESTORS
	
	PINNACLE VENTURES II-A (SUB), L.P.
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer
	
	Address for Notice:
	
	 130 Lytton Avenue, Suite 220

	 Palo Alto, CA 94301

  

			
	Facsimile No.:	 	 (650) 926-7801

	Telephone No.:	 	 (650) 926-7805

	Attn:	 	 Robert N. Savoie

	
	 with a copy (which shall not constitute notice) to:

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	INVESTORS
	
	PINNACLE VENTURES II-B, L.P.
		
	By:	 	 /s/ Robert N. Savoie

	 Name:
	 	Robert N. Savoie
	 Title:
	 	Chief Financial Officer

  

			
	Address for Notice:
	
	 130 Lytton Avenue, Suite 220

	 Palo Alto, CA 94301

		
	 Facsimile No.:
	 	 (650) 926-7801

	 Telephone No.:
	 	 (650) 926-7805

	Attn:	 	 Robert N. Savoie

	
	with a copy (which shall not constitute notice) to:

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	INVESTORS
	
	PINNACLE VENTURES II-C, L.P.
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer

  

			
	Address for Notice:
	
	 130 Lytton Avenue, Suite 220

	 Palo Alto, CA 94301

		
	 Facsimile No.:
	 	 (650) 926-7801

	Telephone No.:	 	 (650) 926-7805

	Attn:	 	 Robert N. Savoie

	
	with a copy (which shall not constitute notice) to:

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	INVESTORS
	
	PINNACLE VENTURES II-R (SUB), L.P.
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer

  

			
	Address for Notice:
	
	 130 Lytton Avenue, Suite 220

	 Palo Alto, CA 94301

		
	Facsimile No.:	 	 (650) 926-7801

	Telephone No.:	 	 (650) 926-7805

	Attn:	 	 Robert N. Savoie

	
	 with a copy (which shall not constitute notice) to:

 SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT 

 SCHEDULE A 
 INVESTORS 
 PINNACLE VENTURES, L.L.C. 
 PINNACLE VENTURES II-A (SUB), L.P. 
 PINNACLE
VENTURES II-B, L.P. 
 PINNACLE VENTURES II-C, L.P. 
 PINNACLE VENTURES II-R (SUB), L.P. 
  

 A-1f8k0310ex10i_wolf.htm

    Exhibit
10.1

     

    AIRLINE
INTELLIGENCE SYSTEMS, INC.

    

    January
1, 2006         

     

     

     

     

    Mr.
Stephen Johnston 

    220-33
Hazelton Ave. 

    Toronto
Ontario M5R 2E3

     

    Dear
Steve:

     

    Re:    Employment
Terms

     

    This
letter agreement (the "Agreement") sets
out the employment terms for your employment with Airline Intelligence Systems,
Inc. (the "Company"), a corporation
incorporated pursuant to the laws of the State of Delaware. This Agreement will
set out additional benefits that you will receive and your obligations to the
Company.

     

    1.            
Duties

     

    You
will hold the position of President and Chief Executive Officer of the Company.
The Company acknowledges that you will also be employed as the Corporate
Secretary of a Canadian wholly-owned subsidiary of the Company, Airline
Intelligence Systems Inc.. an Ontario company (the "Canadian Subsidiary"). You will report to the
Board of Directors of the Company and will devote sufficient time and attention
to performing the duties consistent with your position in the
Company.

     

    2.             Compensation

     

    2.1 Salary.
The Canadian Subsidiary will pay you a salary ("Salary") for your services of
CDNS200.000 per fiscal year, less applicable Canadian withholding of taxes and
other mandatory deductions. The Salary will be bonic by the Company and the
Canadian Subsidiary in an allocation that is reasonable. You will be responsible
for all US federal and state withholding taxes and
deductions.

     

    2.2 Business Expenses. You will be reimbursed for
normal business expenses which you reasonably incur in connection with your
duties as an employee of the Company in accordance with Company policies. You
will provide the Company with complete statements, receipts or vouchers to
support claims for reimbursement of your expenses prior to the receiving
reimbursement. Your expenses will be subject to review from time to time by the
Board of Directors of the Company.

     

    2.3 Vacation. In each 12-month period during the
Term, you will be eligible for 4 weeks of paid vacation to be taken at such
times as may be acceptable to the Company.

     

    If your
employment ends for any reason, you will not be entitled to receive any payment
for unused vacation unless provided by Company policies, or required by
applicable law.

     

    
      
         

      

      
        -1-

        
          

        

      

      
         

      

    

    2.4     Benefits. You will be entitled
to participate in the benefit plans of the Company.

     

    3.            
Term

     

    3.1 Term. This Agreement will
commence as of January 1, 2006,
and will continue indefinitely unless terminated sooner in accordance
with the provisions of this section 3. You must provide at least
6 months' written notice
of termination to the Company. At any time after the receipt by the Company of
your notice of resignation the Company will be entitled to waive that notice,
and your employment will then be terminated immediately. Upon waiver of that
notice, you will receive your regular Salary for the remainder of the then
current term.

     

    3.2 Termination upon Death. Your
employment will terminate upon your death.

     

    3.3 Termination for Cause. The
Company may terminate your employment for cause without notice or further
obligation.

     

    3.4 Termination Without Cause. The
Company is entitled to terminate your employment without cause by advising you
of its decision and by paying you a lump sum payment equal to the Salary that
the Company would have paid to you over a period of 18 months based on your
Salary at the date of termination. Subject to availability and in no event at
any cost to the Company above its regular premiums, you will receive a
continuation of health and dental benefits in Canada for the 18 month period
following your termination. All other benefits will immediately terminate on
your termination.

     

    3.5 Result of Termination. If your
employment is terminated:

     

    
      	
              (a)  

            	
              this
      Agreement will be terminated, except for sections 4.2, 4.3, 4.4, 4.5, 4.6 and 4.7 and any other
      provisions specifically contemplated to continue beyond the termination of
      this Agreement;

            

    

     

    
      	
              (b)  

            	
              you
      will have no claim against the Company, its subsidiaries and their
      respective officers, directors, employees, shareholders or agents for
      damages or any other amounts arising out of or in respect of your
      employment, except for payment of any compensation, benefits or expense
      reimbursement owed to you pursuant to this Agreement on termination under
      this Agreement. At the Company's request, you will re­confirm this
      release in writing as a condition to receiving any payment under section
      3.4;

            

    

     

    
      	
              (c)  

            	
              you
      will promptly return any property of the Company in your
      possession.

            

    

     

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

     

    4.             Your
Obligations

    

    4.1 General Obligations. During
the term of this Agreement, you will:

     

    
      	
              (a)  

            	
              well
      and faithfully serve the Company and carry out the duties assigned to you
      to the best of your ability;

            

    

     

    
      	
              (b)  

            	
              act
      honestly and in good faith with a view to the best interests of the
      Company;

            

    

     

    
      	
              (c)  

            	
              comply
      with all applicable policies of the Company as implemented and amended
      from time to time;

            

    

     

    
      	
              (d)  

            	
              not
      improperly bring to the Company or use any trade secrets, confidential
      information or other proprietary information of any third
      party;

            

    

     

    
      	
              (e)  

            	
              be
      responsible for submitting all US federal and state taxes &
      deductions;

            

    

     

    
      	
              (f)  

            	
              not
      knowingly infringe the intellectual property rights or other rights of any
      third party in the performance of your duties;
  and

            

    

     

    
      	
              (g)  

            	
              by
      entering into this Agreement you confirm that you are not subject to any
      restrictions which might prevent you from being employed by, or carrying
      out any of the duties of your position on behalf of, the
      Company.

            

    

    

    4.2 Confidentiality and Proprietary
Rights. You acknowledge and understand that the Company has expended
significant financial resources in developing its products, services,
intellectual property and confidential information. You agree to be bound by the
provisions of Schedule A attached. Your obligations under Schedule A are to
remain in effect following termination of this Agreement and/or your
employment.

     

    4.3 Non-Competition. You
acknowledge that your services are unique and extraordinary. You also
acknowledge that your position will give you access to confidential information
of substantial importance to the Company and its business. Accordingly, during
the Non-Competition Period (as defined below), other than you being employed by
the Canadian Subsidiary, you will not either individually or in partnership or
jointly or in conjunction with any other person, entity or organization, as
principal, agent, consultant, lender, contractor, employer, employee, investor,
shareholder or in any other manner, directly or indirectly, advise, manage,
carry on, establish, control, engage in, invest in, offer financial assistance
or services to. or permit your name or any part thereof to be used by, any
business that competes, in any jurisdiction the Company operates or proposes to
operate in with the current and future business of the Company, its parent,
affiliated or subsidiary companies, or any planned business in which the
Company, its parent, affiliated or subsidiary companies is engaged
(collectively, the "Business").
Without limiting the generality of the foregoing, this provision
prohibits you from being involved in the solicitation or sale to any customers
of the Business of any products or services sold or provided by the Business.
"Non-Competition Period"
means the period during which you arc employed by the Company and a
period immediately thereafter equal to 24 months. The parties hereto agree that
if in any proceeding before a court of competent jurisdiction, the court shall
refuse to enforce the covenants set forth in section 4.3 because such covenants
cover too extensive a geographic area or too long a period of time, the Court is
expressly authorized to appropriately amend and modify the provision in keeping
with the intention of the parties to give this provision to the maximum scope
permitted by law.

     

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

       

      4.4 Non-Solicitation. During the
applicable Non-Solicitation Period (as defined below), neither you nor any
entity with whom you are at the time associated, or affiliated will, directly or
indirectly, hire or offer to hire or entice away or in any other manner persuade
or attempt to persuade any officer, employee, agent, supplier or customer of the
Business to discontinue or alter any one of their or its relationship with the
Company. You will not assist or procure any other person or entity to do any act
that, if done by you, would constitute a violation of any of your obligations
above. "Non-Solicitation
Period" means the period during which you are employed by the Company and
a period immediately thereafter equal to 24 months.

    

     

    4.5 Validity of Covenants. You
agree that (a) all provisions and restrictions in this Agreement are reasonable
and valid and (b) you waive all defences to the strict enforcement of this
Agreement.

     

    4.6 Injunctive Relief. You agree
that the remedy at law for any breach by you of section 4.2, 4.3 or 4.4 of this
Agreement will be inadequate and that the Company will be entitled to temporary
and permanent injunctive relief against you without the necessity of proving
actual damage to the Company.

     

    4.7 Company Breach No Excuse. You
agree that sections 4.2, 4.3 and 4.4 of this Agreement are enforceable against
you despite any breach or repudiation or alleged breach or repudiation of this
Agreement by the Company, even if the Company terminates you in a fashion that
does not comply with this Agreement or applicable law.

    

    5.            
Notice

     

    Any
notice required or permitted to be given to you will be in writing and will be
sufficiently given if delivered to you personally or mailed by registered or
certified mail, postage prepaid, addressed to you at your address as shown on
the records of the Company. Any such notice which is mailed will be deemed to
have been received by you on the third business day following the date of
mailing.

    

    6.            
Entire Agreement,
Governing l.aw

     

    This
Agreement is the entire agreement between you and the Company with respect to
this subject matter hereof and supersedes any and all prior agreements,
arrangements or understanding between the parties relating to the subject matter
hereof, except written agreements relating to stock option grants. The
provisions of this Agreement will be governed by and interpreted in accordance
with the laws of the State of Delaware.

    

    7.             Severability

     

    The
provisions of this Agreement are severable and the invalidity or
unenforceability of any part will not affect the validity and enforceability of
the other parts. If any part is held to be unenforceable, it will be interpreted
in such a way as to affect most comprehensively
the intention of the parties. If any part is determined to be unenforceable, it
will not impair the validity of any other part and each part is separate and
distinct. The parties will co-operate to replace any severed term of this
Agreement with a replacement provision as close to the severed term as is
legally permissible.

     

    
      
        
           

        

        
          -4-

          
            

          

        

        
           

          
            --

          

        

      

    

    

    8.            
Acknowledgement

    

     

    You
acknowledge that you have had sufficient time to review this Agreement, which
includes Schedule A, thoroughly and to obtain legal advice if desired. You
confirm that you have read and understand the terms of, and your obligations
under, this Agreement.

     

    If this
Agreement is acceptable to you, please sign and return one copy to us. Upon
receipt by the Company of the fully executed copy, this Agreement will be
effective.

     

     

    
      
        	 	AIRLINE INTELLIGENCE SYSTEMS,
      INC.	 
	 	 	 	 
	
                 

              	
                By:
      

              	/s/ Stephen
      Johnston	 
	 	 	Name:
      Stephen Johnston	 
	 	 	Title: Director	 
	 	 	 	 

      

    

    

    
      
        	I agree
      to the terms of this Agreement.	 
	 	 	 
	
                By:
      

              	/s/ Stephen
      Johnston	 
	 	Stephen
      Johnston	 
	 	 	 
	 	 	 

      

       

      

      
        
          
             

          

          
            -5-

            
              

            

          

          
             

          

        

      

      
SCHEDULE
A 

    

     

    CONFIDENTIALITY
AND PROPRIETARY RIGHTS 

     

    AGREEMENT

    

    

     

    1.      Proprietary
Information

     

    
      	
               
      

            	
              (a)

            	
              Your
      employment creates a relationship of confidence and trust between theCompany
      and you with respect to any information which may be made known to you
      by the Company or by any client or customer of the Company, or learned
      by you
      in that context during the period of your employment and
      which:

            

    

     

    
      	
               
      

            	
              (i)

            	
              has
      not been made generally available to the public;
  and

            

    

     

    
      	
               
      

            	
              (ii)

            	
              is
      applicable or of value to the Company's current or anticipated business,
      research
      or development activities, or those of any client or customer of 
      the
      Company.

            

    

     

    
      	
               
      

            	
              (b)

            	
              

                All
      that information has commercial value in the business in which the Company
      is engaged and is referred to in this Agreement as "Proprietary
      Information.'1
      By way of illustration, but not limitation. Proprietary Information
      includes: (i) any and all technical and non-technical information
      including patent disclosures and applications, copyright applications,
      trade secrets, confidential information, techniques, sketches, drawings,
      models, inventions, know-how, processes, apparatus, equipment, algorithms,
      software programs, software source documents, and formulae related to the
      current, future and proposed products and services of the Company; (ii)
      any and all information concerning research, experimental work,
      development, design details and specifications, engineering, financial
      information, procurement requirements, purchasing, manufacturing,
      prospective and current customer lists and information, customer contracts
      and services, business forecasts, cost and pricing information, sales and
      marketing plans and information; and (iii) proprietary or confidential
      information of any of the Company's customers or any other third party who
      may disclose such information to the Company or to you in the course of
      the Company's
  business.

              

            

    

     

    
      	
               
      

            	
              (c)

            	
              

                Proprietary
      Information does not include any information: (i) which has been published
      by others in a form generally available to the public; or (ii) which you
      have received from a third party with the legal right to use that
      information. Proprietary Information will not be deemed to have been
      published merely because individual portions of the information have been
      separately published, but only if all the material features comprising
      such information have been published in combination. Proprietary
      Information will not be considered to be publicly available, if it is made
      public by you in violation of this Agreement or by a third party who has
      no lawful right to hold or disclose the Proprietary Information or who
      does so in violation of any contractual, legal, or fiduciary obligation to
      the
Company.

              

            

    

     

    
      
         

      

      
        -6-

        
          

        

      

      
         

      

    

     

    2.            
Ownership and Nondisclosure of Proprietary Information

     

    All
Proprietary Information is the sole property of the Company, the Company's
assigns or the Company's customers, as the case may be, and the Company, the
Company's assigns or the Company's customers will be the sole and exclusive
owner of all patents, copyrights, mask works, trade secrets and other rights in
the Proprietary Information. You will not acquire any ownership or other
interest in the Proprietary Information. At all times, both during your
employment by the Company and after termination of such employment, you will
keep in confidence and trust all Proprietary Information, and you will not use
or disclose any Proprietary Information or anything directly relating to
Proprietary Information without the written consent of the Company, except and
only as may be necessary in the course of performing your duties as an employee
of the Company.

    

    3.            
Ownership and Return of Materials

     

    All
materials (including, without limitation, documents, drawings, models,
apparatus, sketches, designs, lists, and all other tangible media of expression)
furnished to you by the Company will remain the property of the Company. Upon
termination of your employment, or at any time on the request of the Company
before termination, you will promptly (but no later than five days after the
earlier of your employment's termination or the Company's request) destroy or
deliver to the Company, at the Company's option: (a) all materials furnished to
you by the Company; (b) all tangible media of expression which are in your
possession and which include any Proprietary Information or otherwise relate to
the Company's business; and (c) written certification of your compliance with
your obligations under this sentence.

    

    4.           
 Innovations

     

    As used
in this Schedule A, the term "Innovations" means all
processes, machines, manufactures, compositions of matter, improvements,
inventions (whether or not protectable under patent laws), works of authorship,
information fixed in any tangible medium of expression (whether or not
protectable under copyright laws), moral right, mask works, trademarks, trade
names, trade dress, trade secrets, know-how, ideas (whether or not protectable
under trade secret laws), and all other subject matter protectable under patent,
copyright, moral right, mask work, trademark, trade secret or other laws, and
includes without limitation all new or useful art, combinations, discoveries,
formulae, manufacturing techniques, technical developments, discoveries,
artwork, software, and designs. Innovations includes "Inventions," which is defined
to mean any inventions or discoveries protectable under patent laws. It is also
understood that Innovations subject to copyright will be works made for
hire.

    

    5.            
Records

    

    You will
keep complete, accurate and authentic notes, reference materials, data and
records of all Innovations in the manner and form requested in writing by the
Company of you or of its employees generally. All these materials will be
Proprietary Information upon their creation.

     

    
      
         

      

      
        -7-

        
          

        

      

      
         

      

    

     

    6.         
   Assignment of Innovations

     

    You will
promptly disclose and describe to the Company and you will assign to the Company
or the Company's designee your entire right, title, and interest in and to, each
of the Innovations, and any associated intellectual property rights, which you
may solely or jointly conceive, reduce to practice, create, derive, develop or
make during the period of your employment with the Company, which either: (i)
relate, at the time of conception, reduction to practice, creation, derivation,
development, or making of such Innovation, to the Company's business or actual
or demonstrably anticipated research or development; or (ii) were developed on
any amount of the Company's time or with the use of any of the Company's
equipment, supplies, facilities or trade secret information; or (iii) resulted
from any work you performed for the Company. All such Innovations as described
in this paragraph are referred to in this Agreement as "Company
Innovations."

    

    7.           
 Moral Rights

     

    You
irrevocably waive all moral rights that you may have now or in the future with
respect to the Company Innovations, including, without limitation, any rights
you may have to have your name associated with the Company Innovation, any
rights you may have to prevent the alteration, translation or destruction of the
Company Innovations, and any rights you may have to control the use of the
Company Innovations in association with any product, service, cause or
institution. This waiver may be invoked by the Company, and by any of its
authorized agents or assignees, in respect of any of the Company
Innovations.

    

    8.     
       Future Innovations

     

    You
recognize that Innovations or Proprietary Information relating to your
activities while working for the Company and conceived, reduced to practice,
created, derived, developed, or made by you, alone or with others, within three
months after termination of your employment may have been conceived, reduced to
practice, created, derived, developed, or made, as applicable, in significant
part while employed by the Company. Accordingly, such Innovations and
Proprietary Information will be presumed to have been conceived, reduced to
practice, created, derived, developed, or made, as applicable, during your
employment with the Company and are to be promptly assigned to the Company
unless and until you have established the contrary by written evidence
satisfying the clear and convincing standard of proof.

    

    9.           
 Cooperation in Perfecting Rights to Proprietary Information and
Innovations

     

    
      	
               
      

            	
              (a)
      You will perform, during and after your employment, all acts deemed
      necessary or desirable by the Company to permit and assist the Company, at
      the Company's expense, in obtaining and enforcing the full benefits,
      enjoyment, rights and title throughout the world in the Proprietary
      Information and Innovations. Such acts may include, but are not limited
      to, execution of documents and assistance or co-operation: (i) in the
      filing, prosecution, registration, and memorialization of assignment of
      any applicable patents, copyrights, mask work, or other applications; (ii)
      in the enforcement of any applicable patents, copyrights, mask work, moral
      rights, trade secrets, other proprietary rights; and (iii) in other legal
      proceedings related to the Proprietary Information or
      Innovations.

            

    

     

    
      
         

      

      
        -8-

        
          

        

      

      
         

      

    

     

    
      	
               
      

            	
              (b)
      If the Company is unable for any reason to secure your signature to any
      document required to file, prosecute, register, or memorialize the
      assignment of any patent, copyright, mask work or other applications or to
      enforce any patent, copyright, mask work, moral right, trade secret or
      other proprietary right under any Proprietary Information (including
      improvements thereof) or any Innovations (including derivative works,
      improvements, renewals, extensions, continuations, divisional,
      continuations in part, continuing patent applications, reissues, and
      reexaminations), you hereby irrevocably designate and appoint the Company
      and the Company's duly authorized officers and agents as your attorney,
      with full power of substitution, in your name but on behalf of and at the
      expense of the Company: (i) to execute, file, prosecute, register and
      memorialize the assignment of any such application; (ii)to execute and
      file any documentation required for such enforcement; and (iii) to do all
      other lawfully permitted acts to further the filing, prosecution,
      registration, memorialization of assignment, issuance, and enforcement of
      patents, copyrights, mask works, moral rights, trade secrets or other
      rights under the Proprietary Information, or Innovations, all with the
      same legal force and effect as if executed by you. Such appointment, being
      coupled with an interest, is irrevocable by you and shall not be revoked
      by your insolvency, bankruptcy, death or incapacity and you agree to
      ratify and confirm all that the Company may do or cause to be done
      pursuant to the foregoing.

            

    

     

    10.          
No Violation of Rights of Third Parties

     

    Your
performance of all the terms of this Schedule and as an employee of the Company
does not and will not breach any agreement to keep in confidence proprietary
information, knowledge or data acquired by you prior to your employment with the
Company, and you will not disclose to the Company, or induce the Company to use,
any confidential or proprietary information or material belonging to any
previous employer or others. You arc not a party to any other agreement which
will interfere with your full compliance with this Agreement. You will not enter
into any agreement, whether written or oral, in conflict with the provisions of
this Schedule. In the course of my employment with the Company, you will not
knowingly violate or cause the Company to violate the intellectual property
rights of others.

    

    11.          Survival

     

    This
Schedule: (a) shall survive your employment by the Company; (b) does not in any
way restrict your right or the right of the Company to terminate your employment
at any time, for any reason or for no reason; (c) enures to the benefit of
successors and assigns of the Company; and (d) is binding upon your heirs and
legal representatives.

    

    12.          
Injunctive Relief

     

    A breach
of any of the promises or agreements contained herein will result in irreparable
and continuing damage to the Company for which there will be no adequate remedy
at law, and the Company is entitled to injunctive relief and/or a decree for
specific performance, and such other relief as may be proper (including monetary
damages if appropriate).

     

    
      
        
           

        

        
          -9-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]